Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Graft-versus-Host Disease”

1,698 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,698 results

Testing effectiveness (Phase 2)Looking for participantsNCT06973668
What this trial is testing

Study to Compare Post-transplant Cyclophosphamide, Sirolimus, Ruxolitinib and Post-transplant Cyclophosphamide, Sirolimus, Mycophenolate Mofetil to Prevent Graft Versus Host Disease

Who this might be right for
AML
M.D. Anderson Cancer Center 80
Early research (Phase 1)Looking for participantsNCT06991361
What this trial is testing

Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHD

Who this might be right for
Graft Versus Host Disease (cGvHD)
Leslie Kean 21
Large-scale testing (Phase 3)Looking for participantsNCT02416388
What this trial is testing

Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR

Who this might be right for
Acute Myeloid Leukemia (AML)
University Hospital, Angers 3,100
Testing effectiveness (Phase 2)Study completedNCT01323920
What this trial is testing

Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndrome
Dana-Farber Cancer Institute 35
Post-approval studies (Phase 4)Study completedNCT02713997
What this trial is testing

Anti-inflammatory Therapy to Improve Outcomes After TPIAT

Who this might be right for
Pancreatitis, Chronic; Diabetes; Transplant
University of Minnesota 43
Testing effectiveness (Phase 2)Study completedNCT02176031
What this trial is testing

Phase II Trial of Natalizumab + Prednisone for Initial Therapy of Acute GI GVHD

Who this might be right for
Graft Versus Host Disease
Dana-Farber Cancer Institute 21
Large-scale testing (Phase 3)Ended earlyNCT01163253
What this trial is testing

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 2,867
Post-approval studies (Phase 4)Study completedNCT01009619
What this trial is testing

Azithromycin in Bronchiolitis Obliterans Syndrome

Who this might be right for
Bronchiolitis Obliterans SyndromeGraft RejectionLymphocytic Bronchiolitis+1 more
KU Leuven 83
Post-approval studies (Phase 4)Study completedNCT06837012
What this trial is testing

Duloxetine As an Analgesic in Patients Without Central Sensitivity After Same Sitting Bilateral Total Knee Arthroplasty

Who this might be right for
Osteoarthritis of KneeCentral SensitizationCentral Sensitisation
Orthopaedic Arthroscopy Knee and Shoulder Clinic 106
Testing effectiveness (Phase 2)Study completedNCT01525407
What this trial is testing

Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation

Who this might be right for
Malignant Neoplasm
Fred Hutchinson Cancer Center 83
Not applicableStudy completedNCT03086551
What this trial is testing

Modulating Interaction of Motor Learning Networks in Rehabilitation of Stroke

Who this might be right for
StrokeStroke, ChronicStroke, Middle Cerebral Artery With Infarction
University of Michigan 12
Early research (Phase 1)Study completedNCT01700751
What this trial is testing

Brentuximab Vedotin Prevention of (GVHD) After Unrelated Allogeneic Stem Cell Transplantation

Who this might be right for
Leukemia, Acute MyeloidLeukemia, Lymphoblastic,AcuteMyelodysplastic Syndromes
Washington University School of Medicine 17
Testing effectiveness (Phase 2)Study completedNCT02250300
What this trial is testing

MLN9708 for the Prophylaxis of Chronic Graft-versus-host Disease in Patient Undergoing Allogeneic Transplantation

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation
Mehdi Hamadani 68
Testing effectiveness (Phase 2)Study completedNCT02981602
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Antiviral Activity of IONIS-HBVRx in Treatment-Naïve Patients With Chronic HBV Infection

Who this might be right for
Hepatitis BChronic Hepatitis B Atypical
GlaxoSmithKline 31
Post-approval studies (Phase 4)Active Not RecruitingNCT02386800
What this trial is testing

CINC424A2X01B Rollover Protocol

Who this might be right for
Primary MyelofibrosisPolycythemia VeraGraft Versus Host Disease+2 more
Novartis Pharmaceuticals 279
Large-scale testing (Phase 3)UnknownNCT02270307
What this trial is testing

MSC and Cyclophosphamide for Acute Graft-Versus-Host Disease (aGVHD) Prophylaxis

Who this might be right for
LeukemiaMultiple Myeloma
National Research Center for Hematology, Russia 40
Very early researchStudy completedNCT02117115
What this trial is testing

Abdominal CT to Predict the Risk of Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic+1 more
Washington University School of Medicine 21
Testing effectiveness (Phase 2)Study completedNCT00800839
What this trial is testing

Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide

Who this might be right for
Hematologic DiseasesLeukemiaLymphoma+1 more
M.D. Anderson Cancer Center 56
Early research (Phase 1)UnknownNCT06568328
What this trial is testing

Chimeric Natural Killer Receptor-Universal T Cells for Refractory GVHD

Who this might be right for
Graft vs Host Disease
Fujian Medical University 17
Not applicableStudy completedNCT01521039
What this trial is testing

Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease

Who this might be right for
Acute Graft-versus-Host DiseaseAllogeneic Stem Cell Transplant
Ohio State University Comprehensive Cancer Center 259
Next Page